Treatment of Venous Thromboembolism - The Warfarin Optimal Duration Italian Trial (WODIT)

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.97, Iss.1, 2000-01, pp. : 63-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-Molecular-Weight Heparin: The Optimal Duration of Prophylaxis Against Postoperative Venous Thromboembolism After Total Hip or Knee Replacement

By Heit J.A.

Thrombosis Research, Vol. 101, Iss. 1, 2001-01 ,pp. : 163-173

Elsevier

Access to resources Recommend Favorite

Treatment of Venous Thromboembolism in Cancer Patients

By Lee

Thrombosis Research, Vol. 102, Iss. 6, 2001-06 ,pp. : 195-208

Elsevier

Access to resources Recommend Favorite

Long-term Treatment of Venous Thromboembolism

Current Vascular Pharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 384-392

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

By Kearon C. Ginsberg J.S. Kovacs M.J. for the Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 16-16

Elsevier

Access to resources Recommend Favorite

Management of oral anticoagulants in the treatment of venous thromboembolism

By Pinede L. Duhaut P. Ninet J.

European Journal of Internal Medicine, Vol. 12, Iss. 2, 2001-04 ,pp. : 75-85

Elsevier

Access to resources Recommend Favorite